[Form 4] Gevo, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Agiri Oluwagbemileke Yusuf, Chief Financial Officer of Gevo, Inc. (GEVO), reported sales and plan-related disposals in a Form 4 filing. On 09/04/2025 the reporting person sold 1,731 shares of GEVO common stock to satisfy tax withholding obligations arising from the vesting of a restricted stock award; the sales were made under a 10b5-1 trading plan adopted on 11/22/2024 at a weighted average price of $1.6295 per share (individual trade prices ranged from $1.61 to $1.64). After the reported sale the reporting person beneficially owned 276,104 shares directly and held 18,970.28 shares indirectly through a 401(k) plan. Separately, between 08/20/2025 and 09/04/2025 the reporting person disposed of 7.29 shares under the issuer's 401(k) plan to cover administrative fees. The Form 4 was signed by an attorney-in-fact on 09/05/2025.

Insights

Securities Analyst

TL;DR: Routine, preplanned insider sale to cover taxes; limited immediate market significance.

The reported transaction is a sale of 1,731 shares executed under a 10b5-1 trading plan to satisfy tax withholding on vested restricted stock. The transaction price range ($1.61–$1.64) and weighted average ($1.6295) are disclosed, and post-transaction holdings remain material at 276,104 direct shares plus 18,970.28 indirect shares via a 401(k). There is no indication of opportunistic ad hoc selling or unusual timing in the filing; the existence and use of a 10b5-1 plan reduces information asymmetry about intent. For investors, the sale documents insider liquidity related to compensation rather than a clear signal about company fundamentals.

Corporate Governance Expert

TL;DR: Filing demonstrates procedural compliance with Section 16 and 10b5-1 disclosure requirements.

The Form 4 clearly states the relationship (CFO) and provides the required transaction details, including the plan adoption date and price range. The small 401(k) disposals to cover fees are documented with plan statement reference. Signature by an attorney-in-fact is noted. From a governance perspective, transparent reporting and use of a documented trading plan are positive compliance indicators; the filing does not disclose any change in control, new compensation arrangements, or other governance events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Agiri Oluwagbemileke Yusuf

(Last) (First) (Middle)

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

BUILDING C, SUITE 310

(Street)

ENGLEWOOD CO 80112

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		S(1)		1,731	D	$1.6295(2)	276,104	D
Common Stock								18,970.28(3)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Between August 20, 2025 and September 4, 2025, the reporting person disposed of 7.29 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated August 25, 2025.

	/s/ E. Cabell Massey, Attorney-in-Fact	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Gevo CFO Agiri Yusuf sell according to the Form 4?

The Form 4 reports the sale of 1,731 shares of Gevo common stock on 09/04/2025 to cover tax withholding upon vesting of a restricted stock award.

Was the 09/04/2025 sale part of a trading plan?

Yes. The sales were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on 11/22/2024.

At what price were the shares sold?

The reported weighted average price was $1.6295 per share, with individual transaction prices ranging from $1.61 to $1.64.

How many shares does the reporting person own after the reported transactions?

After the reported sale the reporting person beneficially owned 276,104 shares directly and 18,970.28 shares indirectly through a 401(k) plan.

Were there any other disposals reported?

Yes. Between 08/20/2025 and 09/04/2025, the reporting person disposed of 7.29 shares under the issuer's 401(k) plan to cover administrative fees.